Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $33,333 | 19 | 89.5% |
| Food and Beverage | $3,017 | 175 | 8.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $829.00 | 2 | 2.2% |
| Education | $58.75 | 6 | 0.2% |
| Unspecified | $0 | 13 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Great Lakes Medical Services, LLC | $29,551 | 27 | $0 (2024) |
| Innovative Medical Technologies, LLC | $4,611 | 7 | $0 (2021) |
| Dendreon Pharmaceuticals LLC | $602.77 | 26 | $0 (2019) |
| Astellas Pharma US Inc | $465.51 | 34 | $0 (2022) |
| Antares Pharma, Inc. | $320.31 | 19 | $0 (2022) |
| Allergan, Inc. | $218.98 | 14 | $0 (2022) |
| ABBVIE INC. | $137.47 | 12 | $0 (2022) |
| TOLMAR Pharmaceuticals, Inc. | $133.67 | 10 | $0 (2022) |
| Myovant Sciences Inc. | $107.78 | 6 | $0 (2022) |
| Coloplast Corp | $95.48 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $829.00 | 3 | Great Lakes Medical Services, LLC ($829.00) |
| 2023 | $21.67 | 2 | Boston Scientific Corporation ($21.67) |
| 2022 | $2,057 | 42 | Great Lakes Medical Services, LLC ($1,388) |
| 2021 | $2,302 | 34 | Great Lakes Medical Services, LLC ($1,846) |
| 2020 | $4,468 | 26 | Great Lakes Medical Services, LLC ($4,149) |
| 2019 | $9,349 | 44 | Great Lakes Medical Services, LLC ($8,641) |
| 2018 | $7,527 | 26 | Great Lakes Medical Services, LLC ($7,104) |
| 2017 | $10,685 | 38 | Great Lakes Medical Services, LLC ($5,594) |
All Payment Transactions
215 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/31/2024 | Great Lakes Medical Services, LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Stock option | $29.00 | General |
| 01/24/2024 | Great Lakes Medical Services, LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Stock option | $800.00 | General |
| 2024 | Great Lakes Medical Services, LLC | — | — | — | $0.00 | Ownership |
| 10/02/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 2023 | Great Lakes Medical Services, LLC | — | — | — | $0.00 | Ownership |
| 12/01/2022 | TOLMAR Pharmaceuticals, Inc. | JATENZO (Drug) | Education | In-kind items and services | $0.15 | General |
| Category: Endogenous Testosterone Replacement Therapy | ||||||
| 10/25/2022 | ConvaTec Inc. | GENTLECATH (Device) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: CONTINENCE CARE | ||||||
| 10/24/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 10/21/2022 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Prostate Cancer | ||||||
| 10/10/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: ONCOLOGY | ||||||
| 10/04/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 09/20/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Urology | ||||||
| 09/12/2022 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Prostate Cancer | ||||||
| 08/29/2022 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: Interventional Urology | ||||||
| 08/19/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 08/12/2022 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Prostate Cancer | ||||||
| 08/10/2022 | Cook Medical LLC | RESONANCE (Device) | Food and Beverage | Cash or cash equivalent | $21.00 | General |
| Category: Urology | ||||||
| 07/28/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $15.76 | General |
| Category: Urology | ||||||
| 07/27/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Urology | ||||||
| 07/20/2022 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Prostate Cancer | ||||||
| 07/11/2022 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: HORMONE THERAPY | ||||||
| 07/07/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 06/30/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: Urology | ||||||
| 06/28/2022 | Axonics, Inc. | Axonics (Device), Bulkamid | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Urology | ||||||
| 06/17/2022 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Education | In-kind items and services | $0.39 | General |
| Category: Prostate Cancer | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 213 | 513 | $88,243 | $28,241 |
| 2022 | 30 | 1,987 | 22,213 | $770,454 | $297,279 |
| 2021 | 39 | 2,852 | 46,153 | $1.3M | $478,728 |
| 2020 | 36 | 2,843 | 28,275 | $1.3M | $487,119 |
All Medicare Procedures & Services
109 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 103 | 391 | $46,657 | $15,128 | 32.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 89 | 100 | $32,158 | $10,105 | 31.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 22 | $9,428 | $3,007 | 31.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 443 | 766 | $57,450 | $29,871 | 52.0% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 24 | 208 | $78,000 | $29,766 | 38.2% |
| 52275 | Incision of urethra in male using an endoscope | Office | 2022 | 71 | 71 | $75,746 | $29,156 | 38.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 82 | 487 | $68,233 | $27,225 | 39.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 220 | 303 | $53,183 | $24,246 | 45.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 268 | 277 | $41,550 | $22,295 | 53.7% |
| 52281 | Dilation of urethra using an endoscope | Office | 2022 | 77 | 77 | $49,700 | $17,597 | 35.4% |
| J3490 | Unclassified drugs | Office | 2022 | 13 | 48 | $24,375 | $17,451 | 71.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 103 | 103 | $32,974 | $12,591 | 38.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 89 | 101 | $27,076 | $10,642 | 39.3% |
| 52270 | Incision of urethra in female using an endoscope | Office | 2022 | 31 | 31 | $25,719 | $10,276 | 40.0% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2022 | 17 | 20 | $29,044 | $8,900 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 113 | 119 | $11,900 | $7,691 | 64.6% |
| 52260 | Dilation of bladder using an endoscope under general or spinal anesthesia | Facility | 2022 | 51 | 55 | $38,500 | $7,655 | 19.9% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2022 | 26 | 26 | $18,528 | $7,194 | 38.8% |
| 52265 | Dilation of bladder using an endoscope | Office | 2022 | 26 | 26 | $19,191 | $7,019 | 36.6% |
| 52351 | Diagnostic exam of bladder, urethra, and ureter or kidney using an endoscope | Facility | 2022 | 25 | 26 | $15,684 | $6,063 | 38.7% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2022 | 26 | 26 | $9,843 | $3,818 | 38.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 60 | 67 | $7,233 | $2,885 | 39.9% |
| 52214 | Destruction of tissue of bladder, urethra, or surrounding glands using an endoscope | Facility | 2022 | 18 | 20 | $29,486 | $2,612 | 8.9% |
| 52281 | Dilation of urethra using an endoscope | Facility | 2022 | 20 | 20 | $12,909 | $2,373 | 18.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 33 | 33 | $7,197 | $2,371 | 32.9% |
About Dr. Ashwin Shah, MD
Dr. Ashwin Shah, MD is a Urology healthcare provider based in Monroe, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1710983812.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashwin Shah, MD has received a total of $37,238 in payments from pharmaceutical and medical device companies, with $829.00 received in 2024. These payments were reported across 215 transactions from 35 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($33,333).
As a Medicare-enrolled provider, Shah has provided services to 7,895 Medicare beneficiaries, totaling 97,154 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 109 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Monroe, MI
- Active Since 06/23/2005
- Last Updated 04/15/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1710983812
Products in Payments
- PROVENGE (Drug) $602.77
- XTANDI (Drug) $291.30
- BOTOX (Biological) $222.45
- XYOSTED (Drug) $160.62
- ELIGARD (Drug) $133.52
- Androgel (Drug) $119.80
- ORGOVYX (Drug) $107.78
- Myrbetriq (Drug) $95.50
- NOCDURNA (Drug) $84.86
- Axumin (Drug) $83.30
- OTREXUP (Drug) $74.83
- JATENZO (Drug) $70.00
- MYRBETRIQ (Drug) $66.46
- GEMTESA (Drug) $57.59
- INTERSTIM (Device) $54.29
- Erleada (Drug) $50.67
- ELIQUIS (Drug) $47.21
- FEMALE INCONTINENCE (Device) $44.80
- EVENITY (Biological) $38.07
- UroLift (Device) $33.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Monroe
Dr. David Kang, M.d, M.D
Urology — Payments: $14,178
Daniel Linn, Md, MD
Urology — Payments: $13,864
Odell Dean, M.d, M.D
Urology — Payments: $7,606
Robert Humble, Md, MD
Urology — Payments: $4,042
Dr. Ngii Tazeh, M.d., Ph.d, M.D., PH.D
Urology — Payments: $3,475
Dr. Steven Richards, Md, MD
Urology — Payments: $2,353